Clinical Trial Site

Zurich

1 studies enrolling now · 6 studies all time

What they study most

ANCA-Associated Vasculitis, Acute Hepatic Porphyria, Elevated Urinary Oxalate Levels, Hemophilia A, Hemophilia B, Recurrent Calcium Oxalate Kidney Stone Disease

Studies at this site

• ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) — Recruiting now
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B — Completed
• A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels — Stopped early
• EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) — Completed
• A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients — Completed